Journal of Ayurveda and Integrated Medical Sciences

2025 Volume 10 Number 5 MAY
Publisherwww.maharshicharaka.in

Comprehensive Review of Shatpushpa Siddha Taila Nasya and Tiladi Kwatha: An Ayurvedic Approach to Management of Pushphaghni (PCOS)

Bano S1*, Sharma R2
DOI:10.21760/jaims.10.5.28

1* Sanoor Bano, Post Graduate Scholar, Department of Prasuti Tantra Evam Stri Roga, Post Graduate Institute of Ayurved, Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India.

2 Rashmi Sharma, Associate Professor, Department of Prasuti Tantra Evam Stri Roga, Post Graduate Institute of Ayurved, Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India.

Polycystic ovarian syndrome is a probably fastest growing gynaecological disorder in females of reproductive age group. Many pharmacological drugs have been used to treat PCOS with numerous side effects, which have resulted in the selection of alternative treatments from natural sources. Hence, this review aims to investigate the efficacy of medicinal herbs in regularising ovulation, hyperandrogenism, and other metabolic condition in PCOS. Based on the keywords “polycystic ovarian syndrome” or “medicinal herbs” or “ovarian cysts” or “hyperandrogenism” or “insulin resistance”. Treatment included such as Tiladi Kwatha and Shatpushpa Siddha Taila Nasya in Pushphaghni (PCOS).

Keywords: Polycystic Ovarian Syndrome, Pushphaghni, Tiladi Kwatha, Shatpushpa Taila

Corresponding Author How to Cite this Article To Browse
Sanoor Bano, Post Graduate Scholar, Department of Prasuti Tantra Evam Stri Roga, Post Graduate Institute of Ayurved, Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India.
Email:
Bano S, Sharma R, Comprehensive Review of Shatpushpa Siddha Taila Nasya and Tiladi Kwatha: An Ayurvedic Approach to Management of Pushphaghni (PCOS). J Ayu Int Med Sci. 2025;10(5):193-197.
Available From
https://jaims.in/jaims/article/view/4703/

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2025-04-12 2025-04-26 2025-05-07 2025-05-17 2025-05-27
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
None Nil Not required 11.89

© 2025 by Bano S, Sharma R and Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Download PDFBack To ArticleIntroductionConclusionReferences

Introduction

The term 'drug' originates from French word ‘Drogue,’ meaning a dry herb. According to World Health Organization (WHO), a drug is any substance intended to modify physiological systems or pathological states for benefit of recipient. PCOS is a heterogeneous disorder of unknown aetiology. Many features have been associated with disorder, including ovulatory dysfunction, ‘polycystic ovaries’ on either ultrasonographic or histopathological examination, Menstrual irregularities hirsutism, hyperandrogenaemia, abnormal gonadotrophin concentrations and most recently insulin resistance and hyperinsulinemia.[1] Vitiation of Dosha till manifestation of disease (Roga) is known as Samprapti and Samprapti Vighatana (bring Dosha back to normal state) is known as Chikitsa. The drug is helped to Samprapti Vighatana.[2] Acharya Charka says that Aushadham (Drug) is a part of ‘Chikitsa Chatushpda’[3] The classical description of PCOS is difficult to pinpoint; maximum congruence of PCOS can be coinciding with Pushpaghni. In Ayurvedic context, word "Artava" has two meanings: Anthapusha (ovum) and Bahirpushpa (menstrual blood).[4] We can correlate this disease somewhat with Acharya Kashyapa's Pushpaghni, where Vritha Pushpam can be compared to irregular menstruation or anovulation, Sthula with an obesity feature, and Lomasha Ganda with hirsutism on body.[5]

This article reviews the Ayurvedic formulations of Shatpushpa Siddha Taila and Tiladi Kwatha, specifically focusing on their role in managing Pushpaghni Janya Vikara (Polycystic Ovary Syndrome - PCOS).

Prevalence

Polycystic Ovarian Syndrome (PCOS) is a common female endocrine disorder with prevalence of PCOS has reported incidence rate of 2.2% to 26% worldwide.[6] September 1 marks the start of the PCOS (Polycystic ovary syndrome) awareness monthand is also observed as ‘World PCOS Day of Unity’, an event organised by the PCOS Challenge: The National Polycystic Ovary Syndrome Association.

5 million women affected with PCOS, according to the National Institutes of Health's Office of Disease Prevention.

The World Health Organization estimates that there are one out of forty newly reported cases of PCOS worldwide.

In India ranges from 3.7-22.5% depending on the criteria used for diagnosis.[7] Prevalence of PCOS in adolescents is 9.13% in India.[8]

Rationality of selection of trial drug

The most prevalent metabolic and endocrine illness, PCOS results in an imbalance of hormones, which in turn causes complications like infertility, skin issues, and another severe illness (DM, CVD, etc.).[9]

Modern research states that PCOS is treated with hormone therapy, such as progesterone and oestrogen, which has its own negative effects, including weight gain, hot flashes, hepatotoxicity, nephrotoxicity, and depression.[10] Therefore, creating a PCOS treatment plan that is safe, affordable, conservative, non-invasive, and hormone-free is essential and will have long-term health advantages.

Ayurveda is a wholesome life which not only works on disease but also focus in healthy life style. Ayurveda helps to remove the root cause of the disease. A review of Ayurveda literature was conducted to identify the sources, studies conducted by different scholars on Ayurvedic management of PCOS. Literature reveals that there is no previous study has been carried out on comparative effect on Shatpushpa Siddha Taila Nasya hence keeping this view in mind, Shatpushpa mentioned in Kashyap Samhita chosen for Shodhana. Another drug Tiladi Kwatha Orally as mentioned in gadanigrha was chosen for Shamana in the present study. So, in present study an attempt has been made to compare the combine effect of Shatpushpa Siddha Taila Nasya with Tiladi Kwatha Orally in the management of Pushpaghni w.s.r. to Polycystic Ovary Syndrome.

Ingredients of Shatpushpa Siddha Taila

Shatpushpa indicated by Acharya Kashyapa in Viphalam/Akarmya and Alapartavm. He has vividly described the effect of Shatapushpa on Beejotsarga in the chapter Shatapushpa- Shatavari Kalapadhyaya.[11] In this context, Shatpushpa drugs, when combined with Tila Taila, results in the formation of Shatpushpa Siddha Taila Nasya, which is specifically indicated for the Artava Pravartan.


Ingredients of Shatpushpa Siddha Taila posses’ quality of, Katu-Tikta Rasa, Ushana Veerya, Laghu Ruksha Tikshana guna, Katu Vipak and Vata Kapha Shamak[12] properties. It is also having Rituparvritani, Yonishukravishodhani, Agnivardhini, Vatashamni, Putarprada, Balya, properties and thus it might help in ovulation.[13] Shatpushpa have Phytoestrogen (mixed estrogenic and anti-estrogenic action), Hypercholesterolaemia, Antihyperlipidemic action which helps to maintain hormone level and lipid profile.

PCOS is a result of hormonal imbalance initiating from Hypothalamic-Pituitary Ovary axis. As per Ayurveda, it is said that 'Nasa Hi Shirso Dwaaram' so Nasya would be the appropriate Shodhana[14] procedure to deal with endocrine disorder, where hypothalamus or pituitary gland is involved. Hence Shatpushpa Taila Nasya has been taken in present study.

Shatpushpa Siddha Taila: Composition and Benefits

List of Ingredients of Shatpushpa Siddha Taila

SNIngredientsLatin NameFamilyPart UsedPart
1.Shatpushpa KalkaAnethum sowa Kurz.UmbelliferaeSeed1/4 part
2.TilaSesamum indicum LinnPedaliaceaeSeed1 part
3.Shatpushpa KwathaAnethum sowa Kurz.UmbelliferaeSeed4 part

Shatpushpa Siddha Taila is an Ayurvedic medicated oil prepared using the principles of Sneha Kalpana. The main ingredients include:

  • Shatpushpa (Anethum sowa) - Known for its estrogenic properties, it enhances ovulation and balances hormonal levels.
  • Tila Taila (Sesamum indicum) - A potent Vatashamaka oil, rich in antioxidants and essential fatty acids.

Preparation Method

Shatpushpa Siddha Taila will be made by Reference of “Sneha Kalpana” in Sharangdhar Samhita Madhyam Khanda. (9/1) 1 part of Kalka Darvya and 4 parts of Taila and 16 parts of Kwatha will be mixed and it will be heated till only Sneha (oil) remains.

Step 1 - Shatapushpa of 4 kg and 16 litres of water used for Kwatha preparation. After its reduction to ¼th 4 litres of Kwatha prepared for Taila Paka.

Step 2 - 1/2kg of Shatpushpa coarse powder mixed with water for Kalka preparation.

Step 3 - Murchan of Tila Taila with Murchana Dravya done.

Step 4 - Then prepared Shatpushpa Kwatha, Kalka and Murchit Tila Taila mixed together for Snehapaka.

Step 5 - Examinations for Snehapaka Lakshna was done.

For Nasya - Mridu Paka

For Basti - Madhyam Paka

(Snehpaka by Aacharya Sharangdhara Madhyam Khand chapter - 9)

Pharmacological Properties

  • Phytoestrogenic Action - Helps regulate ovarian function.
  • Hypolipidemic & Antihypercholesterolamic - Supports metabolic health.
  • Ushna Veerya (Hot potency) - Clears blocked menstrual channels (Artavavaha Srotas).
  • Vata-Kapha Shamaka - Balances excess doshas contributing to PCOS.

Nasya Therapy for PCOS: The Ayurvedic dictum 'Nasa Hi Shirso Dwaaram' (the nose is the gateway to the brain) suggests that Nasya treatment can influence the hypothalamic-pituitary-ovarian axis. Shatpushpa Siddha Taila, administered as Nasya, aids in hormonal balance and ovulation regulation.

Analytical Parameters

SNPractical NameShatpushpa Siddha Taila
1.Saponification Value172.23
2.Acid Value5.77
3.Thin -layer Chromatography (TLC)0.125, 0.188, 0.25, 0.50, 0.625, 0.75, 0.813, 0.875, 0.938

Tiladi Kwatha: Composition and Benefits

List of ingredients of Tiladi Kwatha

SNDrugLatin NameUseful partQuantity
1.TilaSesamum indicumSeed (Beeja)1 part
2.SunthiZingiber officinaleRhizome (Kand)1/3 part
3.PippaliPiper longumFruit (Phal)
4.MarichaPiper nigrumFruit (Phal)
5.Bharangi (Brahmanyasti)Clerodendrum serratumRoot (Mool)

Tiladi Kwatha is an herbal decoction recommended for Amenorrhea (Kusumaprodh). Its ingredients include:

  • Tila (Sesamum indicum) - A natural emmenagogue, balances Vata Dosha.
  • Pippali (Piper longum) - Improves metabolism, enhances bioavailability of other herbs.
  • Shunthi (Zingiber officinale) - Acts as a digestive stimulant & anti-inflammatory agent.
  • Maricha (Piper nigrum) - Detoxifies the system, aiding in menstrual regulation.
  • Bharangi (Clerodendrum serratum) - Known for its anti-inflammatory and immune-modulating properties.

Preparation Method:

1. Tila seeds are boiled in water until reduced to 50%.
2. Trikatu (Pippali, Shunthi, Maricha) and Bharangi Churna are added.
3. The decoction is further reduced and filtered before administration.

Pharmacological Properties:

  • Hypoglycaemic & Hypolipidemic - Supports insulin sensitivity.
  • Anti-inflammatory & Antioxidant - Reduces systemic inflammation linked to PCOS.
  • Rasayana (Rejuvenative) - Enhances overall reproductive health.
  • Artavajanana (Menstrual regulator) - Promotes healthy menstrual cycles.

Collection & Preparation of Drugs

The raw herbs were sourced from local markets in Rajasthan, India, and authenticated by the DG Department of DSRRAU, Jodhpur. The formulations were prepared in a controlled environment at the college pharmacy to ensure quality and efficacy.

Analytical & Research Insights

Scientific evaluations of these formulations highlight their bioactive components:

  • Shatpushpa contains limonene, carvone, and phytoestrogens, which regulate ovarian function.
  • Tila Taila is rich in sesamin and sesamolin, known for their cholesterol-lowering effects.

  • Trikatu components (Pippali, Shunthi, Maricha) exhibit anti-inflammatory and metabolic benefits.

Conclusion

Shatpushpa Siddha Taila and Tiladi Kwatha, when used in combination, present a holistic Ayurvedic approach to PCOS management. The drugs selected for this study are Tiladi Kwatha Orally and Shatpushpa Siddha Taila Nasya. Both drugs are having Aartavajanna (effect on hormone level), Srotovishodhana, Garbhshyoutrjaka, Vatanulomana, Deepana, Lekhana and Chedana etc. properties. Due to these properties Dosha returns to their respective Ashaya appropriate functioning of Artavavaha Srotas occurs, Artavajanana and Srotovisodhan. The integration of Nasya therapy and oral herbal decoction addresses hormonal imbalance, improves metabolic health, and restores menstrual regularity. Future clinical studies can further validate their efficacy in modern medical contexts.

References

1. Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online. 2004;8(6):644–8. Available from: www.rbmonline.com [Crossref][PubMed][Google Scholar]

2. Agnivesha. Charaka Samhita, elaborated by Charaka and Dridhabala, with Ayurveda Dipika commentary by Chakrapanidatta. Edited by Yadavji Trikamji Acharya. Nidan Sthana 1/1. Varanasi: Chaukhamba Sanskrit Sansthan; [Crossref][PubMed][Google Scholar]

3. Agnivesha. Charaka Samhita, elaborated by Charaka and Dridhabala, with Ayurveda Dipika commentary by Chakrapanidatta. Edited by Yadavji Trikamji Acharya. Sutra Sthana 9/3. Varanasi: Chaukhamba Sanskrit Sansthan [Crossref][PubMed][Google Scholar]

4. Sushruta. Sushruta Samhita, Ayurvedrasayana Dipika Vyakhya by Dr. Bhaskar Govind Ghanekar. Delhi: Meharchand Lachhmandas Publications; 2/38. p. 41 [Crossref][PubMed][Google Scholar]

5. Vriddha Jivaka. Kashyapa Samhita, Kalpa Sthana, Shatapushpa-Shatavari Kalpa Adhyaya, 5/8. Commentary by Pandit Hemaraja Sharma. 6th ed. Varanasi: Chaukhamba Samskrit Sansthan; 1998 [Crossref][PubMed][Google Scholar]


6. Ganie MA, Vasudevan V, Wani IA, Baba MS, Arif T, Rashid A. Epidemiology, pathogenesis, genetics and management of polycystic ovary syndrome in India. Indian J Med Res. 2019;150(4):333–44. [Crossref][PubMed][Google Scholar]

7. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009 Feb;91(2):456-88. doi: 10.1016/j.fertnstert.2008.06.035. Epub 2008 Oct 23. PMID: 18950759 [Crossref][PubMed][Google Scholar]

8. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011;24(4):223–7. [Crossref][PubMed][Google Scholar]

9. Joham AE, et al. [Complete citation: Joham AE, Teede HJ, Ranasinha S, Zoungas S, Boyle J. Prevalence of infertility and help seeking in women with polycystic ovary syndrome: data from a large community-based cohort study. Hum Reprod. 2015 Apr;30(4):947–56. PubMed PMID: 25654626.] [Crossref][PubMed][Google Scholar]

10. Barry JA, et al. [Complete citation: Barry JA, Hardiman PJ. Saxena R. Risk of endometrial, ovarian, and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):748–58. PubMed PMID: 24688118.] [Crossref][PubMed][Google Scholar]

11. Vriddha Jivaka. Kashyapa Samhita, Kalpa Sthana, Shatapushpa-Shatavari Kalpa Adhyaya, 10–13. Commentary by Pandit Hemaraja Sharma. 6th ed. Varanasi: Chaukhamba Samskrit Sansthan; 1998 [Crossref][PubMed][Google Scholar]

12. Sharma PV. Dravyaguna Vijnana. Vol. 2. 5th ed. Varanasi: Chaukhamba Bharati Academy; 2004. p. 403 [Crossref][PubMed][Google Scholar]

13. Vriddha Jivaka. Kashyapa Samhita, Kalpa Sthana, Shatapushpa-Shatavari Kalpa Adhyaya, 5/6. Commentary by Pandit Hemaraja Sharma. 6th ed. Varanasi: Chaukhamba Samskrit Sansthan; 1998 [Crossref][PubMed][Google Scholar]

14. Agnivesha. Charaka Samhita, elaborated by Charaka and Dridhabala, with Ayurveda Dipika commentary by Chakrapanidatta. Edited by Yadavji Trikamji Acharya. Siddhi Sthana 9/88. Varanasi: Chaukhamba Sanskrit Sansthan [Crossref][PubMed][Google Scholar]

Disclaimer / Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of Journals and/or the editor(s). Journals and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.